Active

AKTUAPHARMA

Switched

BE0463582004

Rechtspersoon Public limited company 1 establishment

Terhulpsesteenweg 6A, 1560 Hoeilaart

Active for

28 year, 2 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ 0

Profit

Caution

€ -115,471

▲ 25% vs 2024

Debts

High

€ 3.2 million

▲ 4% vs 2024

AKTUAPHARMA from Hoeilaart, company number BE0463582004, closed financial year 2025 with a result of € -115,471 after tax. For that financial year AKTUAPHARMA recorded a gross margin of € 0 and equity of € -3.2 million. Compared with financial year 2024, the result moved from € -153,447 to € -115,471. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What happened at AKTUAPHARMA?

What happened at AKTUAPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 115,471. Source: NBB ↗
  • Viatris GX BV stepped down as director. NBB
  • DOCPHARMA BV stepped down as director. NBB
  • Viatris GX BV became a director. NBB
  • DOCPHARMA BV became a director. NBB
  • New establishment in Hoeilaart. KBO
  • Start of the company according to the CBE. KBO

In short

From € 123,418 loss in 2023 to € 115,471 loss in 2025.

A new publication or filing at AKTUAPHARMA? We notify you, reason included.

Follow AKTUAPHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

The shares are held by Docpharma BV (100%) and Matrix Laboratories BV (0%).

See the full network in the app

Directors

According to the 2025 annual accounts

Viatris GX BV

Director · represented by Arun NARAYAN

Owns 100% via Docpharma BV

since 2020 · until 2026

DOCPHARMA BV

Director · represented by Tomasz BUCZEK

since 2020 · until 2026

Shareholders

Docpharma BV · holding of Viatris GX BV

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Terhulpsesteenweg 6A

1560 Hoeilaart

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

Details

Company number
0463.582.004
VAT number
BE 0463.582.004
Registered office
Terhulpsesteenweg 6A, 1560 Hoeilaart
Names & denominations
AKTUAPHARMA
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
16 June 1998
Peppol
Active · Active since 20 Nov 2020

Frequently asked questions

What is the enterprise number of AKTUAPHARMA?
The enterprise number of AKTUAPHARMA is BE0463582004.
What is the address of AKTUAPHARMA?
The registered office of AKTUAPHARMA is located at Terhulpsesteenweg 6A, 1560 Hoeilaart.
When was AKTUAPHARMA founded?
AKTUAPHARMA was founded on 16 June 1998.
Does AKTUAPHARMA have a website?
No website is currently known for AKTUAPHARMA.
How much profit did AKTUAPHARMA make in 2025?
AKTUAPHARMA recorded a loss after taxes of € 115,471 in financial year 2025.
Where can I find the annual accounts of AKTUAPHARMA?
AKTUAPHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of AKTUAPHARMA?
According to the 2025 annual accounts, the directors of AKTUAPHARMA are: Viatris GX BV , DOCPHARMA BV.
Who owns AKTUAPHARMA?
The shares are held by Docpharma BV (100%) and Matrix Laboratories BV (0%).
Who are the shareholders of AKTUAPHARMA?
According to the 2025 annual accounts, the shareholders of AKTUAPHARMA are: Docpharma BV (100%), Matrix Laboratories BV (0%).